Market closedNon-fractional

Alector/ALEC

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Alector

Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.

Ticker

ALEC

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

South San Francisco, United States

Employees

244

Alector Metrics

BasicAdvanced
$425M
Market cap
-
P/E ratio
-$1.40
EPS
0.82
Beta
-
Dividend rate
$425M
0.82
3.525
3.408
16.222
20.992
-13.13%
-66.65%
3.953
2.39
2.39
-1.916
-23.30%
-14.37%
74.84%
-18.36%

What the Analysts think about Alector

Analyst Ratings

Majority rating from 11 analysts.
Buy

Alector Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-227.84% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$16M
4.64%
Net income
-$36M
-13.04%
Profit margin
-227.84%
-16.90%

Alector Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 25.16%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.02
-$0.53
-$0.49
-$0.38
-
Expected
-$0.82
-$0.66
-$0.77
-$0.51
-$0.50
Surprise
-102.44%
-19.36%
-36.44%
-25.16%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Alector stock?

Alector (ALEC) has a market cap of $425M as of July 06, 2024.

What is the P/E ratio for Alector stock?

The price to earnings (P/E) ratio for Alector (ALEC) stock is 0 as of July 06, 2024.

Does Alector stock pay dividends?

No, Alector (ALEC) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next Alector dividend payment date?

Alector (ALEC) stock does not pay dividends to its shareholders.

What is the beta indicator for Alector?

Alector (ALEC) has a beta rating of 0.82. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy or sell Alector stock

Buy or sell Alector stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing